Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 11/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.51 |
| ▸ | GAA | P10253 | 6/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
| ▸ | SLC16A3 | O15427 | 2/20 | 0.48 |
| ▸ | SLC16A1 | P53985 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 8/20 | 0.44 |
| ▸ | MEN1 | O00255 | 3/20 | 0.44 |
| ▸ | LMNA | P02545 | 3/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.44 |
| ▸ | CRHBP | P24387 | 1/20 | 0.44 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.44 |
| ▸ | HTT | P42858 | 3/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.43 |
| ▸ | TYR | P14679 | 2/20 | 0.42 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.42 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20339317 | 0.98 | ALDH1A1 (0.50) | ALDH1A1KDM4EGAAPOLBSLC16A3 | |
| SCHEMBL11858448 | 0.96 | ALDH1A1 (0.51) | ALDH1A1KDM4EGAAPOLBSLC16A3 | |
| SCHEMBL8378029 | 0.95 | SLC16A3 (0.49) | ALDH1A1KDM4EGAAPOLBSLC16A3 | |
| SCHEMBL10853212 | 0.94 | SLC16A3 (0.48) | ALDH1A1KDM4EGAAPOLBSLC16A3 | |
| SCHEMBL28391935 | 0.94 | SLC16A3 (0.48) | ALDH1A1KDM4EGAAPOLBSLC16A3 | |
| SCHEMBL11259764 | 0.94 | SLC16A3 (0.48) | ALDH1A1KDM4EGAAPOLBSLC16A3 | |
| SCHEMBL30665426 | 0.90 | ALDH1A1 (0.47) | ALDH1A1KDM4EGAAPOLBMAPT | |
| SCHEMBL9189739 | 0.90 | ALDH1A1 (0.47) | ALDH1A1KDM4EGAAPOLBMAPT | |
| SCHEMBL11939784 | 0.87 | ALDH1A1 (0.44) | ALDH1A1KDM4EGAAPOLBSLC16A3 | |
| SCHEMBL11939410 | 0.85 | ALDH1A1 (0.47) | ALDH1A1KDM4EGAAPOLBSLC16A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3562815-A1 | A CATALYST COMPOSITION FOR A PRODUCTION PROCESS OF - LACTONE FROM CARBON DIOXIDE AND 1,3-BUTADIENE | PTT Global Chemical Public Company Limited (TH) | 2019-11-06 | — | — | EP | claimed |
| WO-2018124978-A1 | A CATALYST COMPOSITION FOR A PRODUCTION PROCESS OF δ- LACTONE FROM CARBON DIOXIDE AND 1,3-BUTADIENE | PTT GLOBAL CHEMICAL PUBLIC COMPANY LIMITED (TH) | 2018-07-05 | — | — | WO | claimed |
| CN-103451931-B | Carbon fiber surface modifier, modified carbon fiber, matrix material and their preparation method | KINGFA TECHNOLOGY CO., LTD. (CN) | 2015-10-21 | — | — | CN | claimed |
| US-3933847-A | DYES; REACTING A DIAMINE WITH SULFURIC ACID; ALKYLATION | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1976-01-20 | — | — | US | claimed |
| US-12357603-B2 | Acyl sulfonamides for treating cancer | BAYER AKTIENGESELLSCHAFT (DE) | 2025-07-15 | — | — | US | disclosed |
| EP-3959202-B1 | ACYL SULFONAMIDES FOR TREATING CANCER | BAYER AG (DE) | 2023-08-16 | — | — | EP | disclosed |
| US-20220226279-A1 | ACYL SULFONAMIDES FOR TREATING CANCER | THE BROAD INSTITUTE, INC. | 2022-07-21 | — | — | US | disclosed |
| CN-114072394-A | Acylsulfonamides for the treatment of cancer | 拜耳股份公司 | 2022-02-18 | — | — | CN | disclosed |
| US-20220033424-A1 | FLUOROUS METAL CHELATES COMPOSITIONS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2022-02-03 | — | — | US | disclosed |
| EP-3562815-B1 | A CATALYST COMPOSITION FOR A PRODUCTION PROCESS OF DELTA-LACTONE FROM CARBON DIOXIDE AND 1,3-BUTADIENE | PTT GLOBAL CHEMICAL PUBLIC CO LTD (TH) | 2021-12-29 | — | — | EP | disclosed |
| US-11179709-B2 | Catalyst composition for a production process of δ-lactone from carbon dioxide and 1,3-butadiene | PTT GLOBAL CHEMICAL PUBLIC COMPANY LIMITED (TH) | 2021-11-23 | — | — | US | disclosed |
| WO-2020216701-A1 | ACYL SULFONAMIDES FOR TREATING CANCER | BAYER AKTIENGESELLSCHAFT (DE) | 2020-10-29 | — | — | WO | disclosed |
| US-20010053755-A1 | Manganese complexes of hydroxybenzenes or hydroxy-benzo(ij)quinolizines connected by a diimine bridge in 1,2-configuration with the hydroxyl group; preventing dye transfer during laundering | BACHMANN FRANK (DE) | 2001-12-20 | — | — | US | disclosed |
| EP-0902083-A1 | Fabric care method | Ciba SC Holding AG (CH) | 1999-03-17 | — | — | EP | disclosed |
| US-4345073-A | 7,7'-Diamino derivatives of 2,2'-spirodibenzopyranes | BASF AKTIENGESELLSCHAFT (DE) | 1982-08-17 | — | — | US | disclosed |
| US-4316027-A | DYE INTERMEDIATES USED IN THE MANUFACTURE OF PRESSURE SENSITIVE RECORDING MATERIAL | BASF AKTIENGESELLSCHAFT (DE) | 1982-02-16 | — | — | US | disclosed |
| US-4260776-A | PYRAZOLONE | BAYER AKTIENGESELLSCHAFT (DE) | 1981-04-07 | — | — | US | disclosed |
| US-4110348-A | PRESSURE SENSITIVE RECORDING | BASF AKTIENGESELLSCHAFT (DE) | 1978-08-29 | — | — | US | disclosed |
| US-3985763-A | DYESTUFFS | BAYER AKTIENGESELLSCHAFT (DT) | 1976-10-12 | — | — | US | disclosed |
| US-3933847-A | DYES; REACTING A DIAMINE WITH SULFURIC ACID; ALKYLATION | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1976-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220226279-A1 | ACYL SULFONAMIDES FOR TREATING CANCER | KAT6A, KAT6B, KAT2A | ALDH1A1 1645/4885KDM4E 461/4885GAA 1486/4885 |
| US-12357603-B2 | Acyl sulfonamides for treating cancer | KAT6A, KAT6B, KAT2A | ALDH1A1 1645/4885KDM4E 461/4885GAA 1486/4885 |
| US-20220033424-A1 | FLUOROUS METAL CHELATES COMPOSITIONS | KAT6A, SLC6A12, SLC6A6 | ALDH1A1 3193/4885KDM4E 1582/4885GAA 1071/4885 |
| US-11179709-B2 | Catalyst composition for a production process of δ-lactone from carbon dioxide and 1,3-butadiene | CTNND1, DHCR24, DEGS1 | ALDH1A1 1846/4885KDM4E 3412/4885GAA 1546/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.